UK diagnostics firm Intelligent Fingerprinting has joined forces with Imperial College London to develop fingerprint testing technology for Covid-19.
Intelligent Fingerprinting’s sweat-based fingerprint diagnostics platform has already proven itself as a drug test system, but will now be repurposed to test for SARS-CoV-2. The highly sensitive lateral flow technology and fluorescence measurement techniques within a portable test reader could help to create a point-of-care test that allows Covid-19 testing to be carried out quickly and safely, without the need for specialist training.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Imperial College director of global health Lord Darzi said: “Adding rapid point-of-care testing capacity would help us to get much closer to understanding the spread of the virus. Fingerprint testing using a portable system would also be particularly valuable in supporting simple and easy testing by non-medically trained staff at multiple sites across the UK, such as care homes and workplaces.”
